Antibacterial Activity of and Against ESKAPE Pathogens.

Front Pharmacol

Center for the Study of Human Health, Emory College of Arts and Sciences, Atlanta, GA, United States.

Published: February 2019

Plants in the genus (Family: Crassulaceae) are used in traditional medicine throughout the tropics for treating a variety of conditions. Two species, and , have established ethnobotanical usage but have been neglected in previous research concerning their potential bioactivity. Here, we provide a thorough review of the reported antimicrobial activities of genus and evaluate the antibacterial effects of two previously unexplored species against a panel of multidrug-resistant bacteria, the ESKAPE pathogens (, and ). Plant specimens were collected and voucher specimens deposited in the Emory University Herbarium. Dried plant material was ground into a powder and extracted as ethanolic macerations or as aqueous decoctions. Extracts were tested against the ESKAPE pathogens for growth inhibitory activity. Cytotoxicity to human cells was assessed via a lactate dehydrogenase assay of treated human keratinocytes (HaCaTs). extracts demonstrated growth inhibitory effects against two Gram-negative species, (strain CDC-33) and (AH-71), as well as (UAMS-1). In these cases, growth inhibition greater than 50% (IC) was generally observed at concentrations of 256 μg mL, though one extract (1465, prepared from stems) exhibited an IC against at 128 μg mL. All extracts were well tolerated by HaCaTs (LD ≥ 256 μg mL). Chemical characterization using HPLC and chemical standards established the presence of caffeic acid and quercetin in both plant species, as well as kaempferol in These results reveal to be a plant of medicinal interest, and future research should aim to characterize the bioactivity of this species and its active constituents through bioassay-guide fractionation. Effects on bacterial biofilm formation and quorum-sensing are also research topics of interest for this genus.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374630PMC
http://dx.doi.org/10.3389/fphar.2019.00067DOI Listing

Publication Analysis

Top Keywords

eskape pathogens
12
growth inhibitory
8
256 μg
8
species
5
antibacterial activity
4
activity eskape
4
pathogens plants
4
plants genus
4
genus family
4
family crassulaceae
4

Similar Publications

The World Health Organization has identified multidrug-resistant bacteria as a serious global health threat. Gram-negative bacteria are particularly prone to antibiotic resistance, and their high rate of antibiotic resistance has been suggested to be related to the complex structure of their cell membrane. The outer membrane of Gram-negative bacteria contains lipopolysaccharides that protect the bacteria against threats such as antibiotics, while the inner membrane houses 20-30% of the bacterial cellular proteins.

View Article and Find Full Text PDF
Article Synopsis
  • Antimicrobial resistance (AMR) is a significant global public health issue, prompting this study to examine antibacterial usage and the prevalence of multidrug-resistant organisms (MDRO) in a Brazilian hospital, particularly focusing on the ESKAPE group pathogens.
  • The study employed a time series approach, analyzing data from January 2015 to December 2021, revealing increased consumption of specific antibiotics like daptomycin and linezolid, and a noteworthy rise in the incidence of certain MDROs, especially Staphylococcus spp and Enterococcus spp.
  • Findings suggest that the COVID-19 pandemic may have worsened the trends of rising AMR, highlighting the need for ongoing surveillance to understand these epidemiological changes better.
View Article and Find Full Text PDF

Multidrug antimicrobial resistance (AMR) represents a formidable challenge in the therapy of infectious diseases, triggered by the particularly concerning gram-negative , , , , , and spp. (ESKAPE) pathogens. Designated as a "priority" in 2017, these bacteria continue to pose a significant threat in 2024, particularly during the worldwide SARS-CoV-2 pandemic, where coinfections with ESKAPE members contributed to worsened patient outcomes.

View Article and Find Full Text PDF

NIAID Workshop Report: Systematic Approaches for ESKAPE Bacteria Antigen Discovery.

Vaccines (Basel)

January 2025

Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.

On 14-15 November 2023, the National Institute of Allergy and Infectious Diseases (NIAID) organized a workshop entitled "Systematic Approaches for ESKAPE Bacteria Antigen Discovery". The goal of the workshop was to engage scientists from diverse relevant backgrounds to explore novel technologies that can be harnessed to identify and address current roadblocks impeding advances in antigen and vaccine discoveries for the ESKAPE pathogens (, , , , and species). The workshop consisted of four sessions that addressed ESKAPE infections, antigen discovery and vaccine efforts, and new technologies including systems immunology and vaccinology approaches.

View Article and Find Full Text PDF

New technology has opened opportunities for research and exploration of deep-water ecosystems, highlighting deep-sea coral reefs as a rich source of novel bioactive natural products. During our ongoing investigation of the chemodiversity of the Irish deep sea and the soft coral we report 12 unreported cadinene-like functionalized sesquiterpenes, anthoteibinenes F-Q. The metabolites were isolated using both bioassay- and H NMR-guided approaches.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!